A 4-Year Retrospective Claims Analysis of Oral Corticosteroid Use and Health Conditions in Newly Diagnosed Medicare FFS Patients with COPD

References

• Silverman EK, Crapo JD, Make BJ. Chronic Obstructive Pulmonary Disease. In: Jameson J, Fauci A, Kasper D, Hauser S, Longo D, Loscalzo J, editors. Harrison’s Principles of Internal Medicine, 20e. McGraw Hill; 2018:1–15.
   Google Scholar
• Centers for Disease Control and Prevention. BRFSS Prevalence & Trends Data; 2020. Available from: https://www.cdc.gov/brfss/brfssprevalence/. Accessed November 4, 2021.
   Google Scholar
• Tellez D, Gondalia R, Barrett M, Benjafield A, Nunez CM, Malhotra A. An Estimate of the Americas’ Prevalence of Chronic Obstructive Pulmonary Disease in 2050. Am J Respir Crit Care Med. 2021;2;A2274–A2274. doi:10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a2274
   Google Scholar
• Ford ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥ 18 years in the United States for 2010 and projections through 2020. Chest. 2015;147(1):31–45. doi:10.1378/chest.14-0972
   PubMed Web of Science ®Google Scholar
• Çolak Y, Afzal S, Marott JL, et al. Prognosis of COPD depends on severity of exacerbation history: a population-based analysis. Respir Med. 2019;155:141–147. doi:10.1016/j.rmed.2019.07.021
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease (2022 Report); 2022. Available from: https://goldcopd.org/2022-gold-reports/. Accessed September 20, 2022.
   Google Scholar
• Walters JAE, Tan DJ, White CJ, Wood-Baker R. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease. Cochrane Database Sys Rev. 2018;1(3). doi:10.1002/14651858.CD006897.pub2
   Web of Science ®Google Scholar
• Nici L, Aaron SD, Alexander PE, et al. Pharmacologic Management of Chronic Obstructive Pulmonary Disease An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(9):E56–E69. doi:10.1164/RCCM.202003-0625ST
   PubMed Web of Science ®Google Scholar
• Waljee AK, Rogers MAM, Lin P, et al. Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study. BMJ. 2017;357:j1415. doi:10.1136/bmj.j1415
   PubMed Web of Science ®Google Scholar
• Zeiger RS, Schatz M, Li Q, Chen W, Khatry DB, Tran TN. Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma. J Allergy Clin Immunol. 2017;5(4):1050–1060.e9. doi:10.1016/j.jaip.2016.12.023
   Web of Science ®Google Scholar
• Sullivan PW, Ghushchyan VH, Globe G, Schatz M. Oral corticosteroid exposure and adverse effects in asthmatic patients. J Allergy Clin Immunol. 2018;141(1):110–116.e7. doi:10.1016/j.jaci.2017.04.009
   PubMed Web of Science ®Google Scholar
• Price DB, Trudo F, Voorham J, et al. Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study. J Asthma Allergy. 2018;11:193–204. doi:10.2147/JAA.S176026
   PubMed Web of Science ®Google Scholar
• Price D, Castro M, Bourdin A, Fucile S, Altman P. Short-course systemic corticosteroids in asthma: striking the balance between efficacy and safety. Eur Respir Rev. 2020;29(155):155. doi:10.1183/16000617.0151-2019
   Web of Science ®Google Scholar
• Luskin AT, Antonova EN, Broder MS, Chang EY, Omachi TA, Ledford DK. Health care resource use and costs associated with possible side effects of high oral corticosteroid use in asthma: a claims-based analysis. ClinicoEconomics Outcomes Res. 2016;8:641–648. doi:10.2147/CEOR.S115025
   PubMed Web of Science ®Google Scholar
• Tran TN, MacLachlan S, Hicks W, et al. Oral Corticosteroid Treatment Patterns of Patients in the United States with Persistent Asthma. J Allergy Clin Immunol. 2020;1:5. doi:10.1016/j.jaip.2020.06.019
   Web of Science ®Google Scholar
• McEvoy CE, Ensrud KE, Bender E, et al. Association between corticosteroid use and vertebral fractures in older men with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(3PART I):704–709. doi:10.1164/ajrccm.157.3.9703080
   PubMed Web of Science ®Google Scholar
• Smyllie HC, Connolly CK. Incidence of serious complications of corticosteroid therapy in respiratory disease. A retrospective survey of patients in the Brompton hospital. Thorax. 1968;23(6):571–581. doi:10.1136/thx.23.6.571
   PubMed Web of Science ®Google Scholar
• Decramer M, Lacquet LM, Fagard RRP. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med. 1994;150(1):11–16. doi:10.1164/ajrccm.150.1.8025735
   PubMed Web of Science ®Google Scholar
• Rice JB, White AG, Scarpati LM, Wan G, Nelson WW. Long-term Systemic Corticosteroid Exposure: a Systematic Literature Review. Clin Ther. 2017;39(11):2216–2229. doi:10.1016/j.clinthera.2017.09.011
   PubMed Web of Science ®Google Scholar
• Research Data Assistance Center. Innovator Research FAQs; 2021. Available from: https://resdac.org/innovator-research-faqs. Accessed November 3, 2021.
   Google Scholar
• Centers for Medicare & Medicaid Services (CMS). Risk Adjustment; 2021. Available from: https://www.cms.gov/Medicare/Health-Plans/MedicareAdvtgSpecRateStats/Risk-Adjustors. Accessed January 23, 2022.
   Google Scholar
• Donaldson G, Hurst J, Smith C, Hubbard R, Wedzicha J. Increased Risk of Myocardial Infarction and Stroke Following Exacerbation of COPD. Chest. 2010;137(5):1091–1097. doi:10.1378/chest.09-2029
   PubMed Web of Science ®Google Scholar
• Ritchie AI, Wedzicha JA. Definition, Causes, Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations. Clin Chest Med. 2020;41(3):421–438. doi:10.1016/j.ccm.2020.06.007
   PubMed Web of Science ®Google Scholar
• Morgan AD, Zakeri R, Quint JK. Defining the relationship between COPD and CVD: what are the implications for clinical practice? Ther Adv Respir Dis. 2018;12:1753465817750524. doi:10.1177/1753465817750524
   Web of Science ®Google Scholar
• Shavelle RM, Paculdo DR, Kush SJ, Mannino DM, Strauss DJ. Life expectancy and years of life lost in chronic obstructive pulmonary disease: findings from the NHANES III Follow-up Study. Int J COPD. 2009;4(1):137–148. doi:10.2147/copd.s5237
   Google Scholar
• Murray CJL, Mokdad AH, Ballestros K, et al. The state of US health, 1990-2016: burden of diseases, injuries, and risk factors among US states. JAMA. 2018;319(14):1444–1472. doi:10.1001/jama.2018.0158
   PubMed Web of Science ®Google Scholar